These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2469244)

  • 1. Prostate-specific antigen in management of prostatic carcinoma.
    Brawer MK; Lange PH
    Urology; 1989 May; 33(5 Suppl):11-6. PubMed ID: 2469244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
    Buamah PK; Johnson P; Skillen AW
    Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prostate-specific antigen determination in prostatic carcinoma.
    Tizzani A; Casetta G; Piana P; Bellina M; Pecchio F; Aimo G; Adamo R
    Int J Biol Markers; 1987; 2(3):184-6. PubMed ID: 2453594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen (PSA) in the management of 500 prostatic patients.
    Guillet J; Role C; Duc AT; François H
    Am J Clin Oncol; 1988; 11 Suppl 2():S61-2. PubMed ID: 2468274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
    Csapo Z; Brand K; Walther R; Fokas K
    J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen. A review.
    Brawer MK
    Acta Oncol; 1991; 30(2):161-8. PubMed ID: 1709355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of prostatic acid phosphatase and prostatic specific antigen in the diagnosis of prostatic cancer.
    van Dalen A; Helmhout DH; van Caubergh RD
    Int J Biol Markers; 1988; 3(2):123-6. PubMed ID: 2468722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is acid phosphatase (PAP) still justified in the management of prostatic cancer?
    Kontturi M
    Acta Oncol; 1991; 30(2):169-70. PubMed ID: 1709356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
    Mulders TM; Bruning PF; Bonfrer JM
    Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
    van Dieijen-Visser MP; Hendriks MW; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 Sep; 177(1):77-80. PubMed ID: 2460272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
    Rock RC; Chan DW; Bruzek D; Waldron C; Oesterling J; Walsh P
    Clin Chem; 1987 Dec; 33(12):2257-61. PubMed ID: 2446807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
    Hetherington JW; Siddall JK; Cooper EH
    Eur Urol; 1988; 14(1):1-5. PubMed ID: 2449352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
    Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC
    Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on PAP, gamma-Sm and PA as tumor markers in prostatic cancer patients].
    Ohashi T; Akagi T; Irie S; Obama T; Nasu Y; Tohjoh S; Takeda K; Yoshimoto J; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1403-8. PubMed ID: 2449560
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
    Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
    van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the markers PAP-PSA in the diagnosis of cancer of the prostate].
    Petrone U; Gaspari G; Marascia G; Magnocavallo N; Petrone D; Tucci C
    Minerva Urol Nefrol; 1990; 42(2):73-5. PubMed ID: 1697431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.